Cite
Xie C, Duffy AG, Brar G, et al. Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2021;27(1):358doi: 10.1158/1078-0432.CCR-20-4640.
Xie, C., Duffy, A. G., Brar, G., Fioravanti, S., Mabry-Hrones, D., Walker, M., Bonilla, C. M., Wood, B. J., Citrin, D. E., Gil Ramirez, E. M., Escorcia, F. E., Redd, B., Hernandez, J. M., Davis, J. L., Gasmi, B., Kleiner, D., Steinberg, S. M., Jones, J. C., & Greten, T. F. (2021). Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(1), 358. https://doi.org/10.1158/1078-0432.CCR-20-4640
Xie, Changqing, et al. "Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,1 (2021): 358. doi: https://doi.org/10.1158/1078-0432.CCR-20-4640
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF. Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2021 Jan 01;27(1):358. doi: 10.1158/1078-0432.CCR-20-4640. PMID: 33397682.
Copy
Download .nbib
